FDA Grants Fast Track to Edesa Biotech's ARDS Drug Candidate
Fast Track improves the speed and frequency of communication with FDA, potentially leading to earlier drug approval and access by patients.TORONTO, ON / ACCESSWIRE / December 20, 2022 / Edesa Biotech, Inc. (Nasdaq:EDSA), a clinical-stage …
Weiterlesen »